NorthWest Biotherapeutics Inc (NWBO)

[iclight]

They couldn't differentiate between ePD or psPD so they didn't want either in the main trial.

from NWBO PR:

"During 2011 and 2012, in addition to conducting the trial, the Company also treated 55 GBM patients with DCVax-L on a compassionate basis in an “Information Arm” outside of the Phase III trial. These 55 patients received the same DCVax-L treatment regimen used in the trial, at medical centers participating in the trial. The 55 patients were not eligible for the Phase III trial because they were either definitely or potentially “rapid progressors”: patients with such an aggressive form of GBM that their tumor was already re-growing during the 6 weeks of daily radiation to the brain and daily chemotherapy which followed the surgical removal of their original tumor as part of the current standard of care."

Potentially = psPD.